Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Zoldonrasib
Related studies linked through entity extraction aliases.
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Status
- RECRUITING
- Phase
- PHASE3
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2